El Said, Mohammed ORCID: 0000-0001-9409-1481
(2025)
Patent Linkage, Data Exclusivity and Public Health: Approaches for Reform.
Journal of Intellectual Property Law & Practice
.
ISSN 1747-1532
![]() |
PDF (AAM)
- Accepted Version
Restricted to Repository staff only until 22 July 2027. 536kB |
Official URL: https://academic.oup.com/jiplp
Abstract
The COVID-19 Pandemic exposed the fragility of the global public health regime. Never before in history, we had a vaccine for an ongoing pandemic which the majority had no access to. However the challenges facing access to medicines preceded Even prior to the COVID-19 Pandemic, as the global public health regime was already showing signs of vulnerability manifested by the rising costs of medicines and public health expenditure levels, increased levels of legal monopolies exasperated by originator drug manufacturers activities, and the widening gap between those who can afford medicines and therapeutic treatments, and those who can’t, even for those residing in developed countries. In fact, global spending on pharmaceuticals is forecast to exceed pre-pandemic outlook to $1.2 trillion by 2028. At a time when the world started to recover from the negative impact of the COVID-19 Pandemic, fears about the potential arrival of a new pandemic arising from the outbreak of Mpox in Africa started to emerge thus putting more strain on public health providers everywhere.
Repository Staff Only: item control page